Accordingly, monocytes from CLL patients inhibit T cell proliferation, an effect abrogated by anti-TGFβ, anti-IL10 antibodies and IDO inhibitor, and support Treg expansion (68). Here, IDO1 is linked to B-cell chronic lymphocytic leukemia.